Table 2.
Demographic, clinical and biochemical parameters in COVID-19 patients and matched controls.
| All subjects (n = 353) | COVID-19 (n = 90) | Controls (n = 263) | Pa | |
|---|---|---|---|---|
| Male (%) | 65.4 | 65.5 | 65.4 | 0.543 |
| Age (years) | 53.9 ± 10.9 | 54.5 ± 11.6 | 53.7 ± 10.6 | 0.509 |
| Body mass index (Kg/m2) | 28 [26–31] | 28 [26–31] | 28 [26–31] | 0.340 |
| Type 2 diabetes mellitus (%) | 19.8 | 38.9 | 13.3 | <0.001 |
| Hypertension (%) | 17.8 | 44.4 | 8.7 | <0.001 |
| Creatinine (mg/dL) | 0.88 [0.71–1.06] | 0.85 [0.59–1.35] | 0.89 [0.74–1.04] | 0.006 |
| Alanine aminotranferase (U/L) | 27 [20–44] | 38 [21–62] | 25 [19–37] | <0.001 |
| Aspartate aminotranferase (U/L) | 26 [21–35] | 34 [22–55] | 25 [21−31] | <0.001 |
| Alkaline phosphatase (U/L) | 80 [66–99] | 88 [67–115] | 79 [66–94] | 0.010 |
Data are shown as mean ± standard deviation, median [interquartile range] or percentage.
a
Student's t-test, Mann Whitney's U test or Chi square test as appropriate.